Skip to main content
Clinical Trials/NL-OMON38535
NL-OMON38535
Completed
Not Applicable

Gene expression analysis elucidating pathogenic mechanisms and predicting vespid venom anaphylaxis - GEIVA

niversitair Medisch Centrum Groningen0 sites20 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Vespid venom allergy
Sponsor
niversitair Medisch Centrum Groningen
Enrollment
20
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • \* A clear positive history of a systemic response grade II, III or IVa after a vespid sting
  • \* Vespid specific serum IgE \> 0\.35 kUA/l or a positive intracutaneous skin test for vespid venom (at \<\= 1 µg/ml a histamine equivalent prick of \>\=0\.7\)
  • written informed consent

Exclusion Criteria

  • \* A positive history of a systemic response grade IVb according to Mueller (13\) after a vespid sting
  • \* Age under 18 years or above 65 years
  • \* Incapacitated subjects
  • \* Severe cardiopulmonary disease (clinical evidence of congestive heart failure, coronary disease or severe hypertension)
  • \* Insufficiently controlled asthma based on history, asthma control questionnaire and if the observed FEV1 is 70% of predicted.
  • \* Conditions that influence the immune system (immune deficiencies, malignancy, auto\-immune diseases, flulike dissease)
  • \* Severe kidney failure
  • \* Interfering medication with the outcome or recovery from a systemic reaction (β\-blockers and immunosuppressive drugs)
  • \* Pregnancy(measured before inclusion by β\-hCG)
  • \* Mastocytosis

Outcomes

Primary Outcomes

Not specified

Similar Trials